The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Thu, 03rd Feb 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Omega Diagnostics Group PLC, up 24% at 11.76 pence, 12-month range 6.50p-117.98p. The Alva, Scotland-based medical diagnostics company successfully attains a CE mark for its Visitect Covid-19 antigen test. "The company remains in discussions with commercial partners about how best to service the European market and other territories that recognise the CE mark. Omega's commercial offering will be via B2B partners and distributors, and not through a direct-to-consumer strategy," Omega adds.

----------

Creo Medical Group PLC, up 16% at 137.00 pence, 12-month range 116.50p-236.00p. The medical device company, with a focus on surgical endoscopy expects revenue for 2021 to top expectations at "just over" GBP25 million from GBP9.4 million in 2020.

----------

AIM - LOSERS

----------

Actual Experience PLC, down 15% at 12.90p, 12-month range 12.00p-135.00p. The Bath-based analytics-as-a-service company says its annual loss widens to GBP5.9 million in 2021 from GBP5.0 million in 2020. Revenue declines 11% to GBP1.7 million from GBP2.0 million. "Our sales team are engaged, directly or with partners, in multiple sales opportunities. Our clear focus in the coming months is to convert these opportunities to recurring 'continuous improvement' revenue streams," the company explains. Actual Experience accepts that shareholders have been "frustrated" with progress to date. "However, one of these lessons is that sales cycles will typically be longer than initially expected and therefore our planning has been adjusted to accommodate this timing," the company adds. Shares hit their 12-month low on Thursday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Sep 2021 12:39

IN BRIEF: Omega Diagnostics awaits approval for home use of Visitect

IN BRIEF: Omega Diagnostics awaits approval for home use of Visitect

Read more
6 Sep 2021 12:04

Omega Diagnostics files for CE-mark on Covid-19 self-test

(Sharecast News) - Medical diagnostics company Omega announced on Monday that all of the supporting data and documentation relating to its submission for CE-marking for self-test use of its 'Visitect' Covid-19 antigen test had been filed with its European notified body.

Read more
13 Jul 2021 15:05

Omega Diagnostics annual loss narrows; finance director leaves

Omega Diagnostics annual loss narrows; finance director leaves

Read more
6 Jul 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Jul 2021 11:41

AIM WINNERS & LOSERS: Microsaic up on new mass spectrometry technology

AIM WINNERS & LOSERS: Microsaic up on new mass spectrometry technology

Read more
2 Jul 2021 10:14

Omega Diagnostics Covid antigen test takes step closer to US approval

Omega Diagnostics Covid antigen test takes step closer to US approval

Read more
8 Jun 2021 14:29

IN BRIEF: Omega Diagnostics tests seek regulator approval in US and EU

IN BRIEF: Omega Diagnostics tests seek regulator approval in US and EU

Read more
8 Jun 2021 09:26

Omega Diagnostics progresses Covid-19 test with EU, US regulators

(Sharecast News) - Medical diagnostics company Omega updated the market on regulatory approvals for the 'Visitect' Covid-19 antigen test on Tuesday, confirming that it has started engaging with its European notified body, seeking CE-marking of the test.

Read more
7 Jun 2021 17:59

TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent

TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent

Read more
7 Jun 2021 10:36

Omega still waiting on government for Covid-19 test manufacture details

(Sharecast News) - Medical diagnostics company Omega updated the market on its UK government manufacturing contract on Monday, reporting that it remained in regular dialogue with the Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests.

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
30 Apr 2021 13:35

Omega Diagnostics launches Visitect Covid-19 antigen test

(Sharecast News) - Omega Diagnostics announced the launch of its 'Visitect' Covid-19 antigen test on Friday, which it described as a rapid point-of-care diagnostic test for the detection of active Covid-19 infections.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.